Showing results (1281-1290 of 1,523) with videos related to
Sort By:
Pageof 153
Journal for Immunotherapy of Cancer|June 21, 2020
Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 studyLin Shen, Jun Guo, Qingyuan Zhang, et al.Innovation (Cambridge (Mass.))|November 11, 2024
Beyond low-density lipoprotein cholesterol levels: Impact of prior statin treatment on ischemic stroke outcomesZi-Mo Chen, Jing-Lin Mo, Kai-Xuan Yang, et al.The Journal of Biological Chemistry|July 13, 2026
Decoding of amidated aromatic C-terminus and sulfation by cholecystokinin receptors reveals conserved and divergent evolutionary mechanismsJian-Hui Chang, Shao-Qian Wu, Xue-Ying Ding, et al.JTO Clinical and Research Reports|September 30, 2021
Outcomes With Pembrolizumab Monotherapy in Patients With Programmed Death-Ligand 1-Positive NSCLC With Brain Metastases: Pooled Analysis of KEYNOTE-001, 010, 024, and 042Aaron S Mansfield, Roy S Herbst, Gilberto de Castro, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 20, 2019
Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical TrialYi-Long Wu, Shun Lu, Ying Cheng, et al.Clinical Lung Cancer|October 12, 2015
Anaplastic Lymphoma Kinase Variants and the Percentage of ALK-Positive Tumor Cells and the Efficacy of Crizotinib in Advanced NSCLCYuan-Yuan Lei, Jin-Ji Yang, Xu-Chao Zhang, et al.Advanced Materials (Deerfield Beach, Fla.)|July 7, 2025
Carbon Doped Boron Nitride Nano-Coatings for Durable, Low Emissivity Glass WindowsAbhijit Biswas, Shancheng Wang, Cody L Milne, et al.Science Bulletin|June 3, 2023
U-shaped association between low-density lipoprotein cholesterol levels and risk of all-cause mortality mediated by post-stroke infection in acute ischemic strokeZi-Mo Chen, Hong-Qiu Gu, Jing-Lin Mo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2024
RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung CancerDavid R Spigel, Afshin Dowlati, Yuanbin Chen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 27, 2016
Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung CancerMartin Reck, Alexander Luft, Aleksandra Szczesna, et al.Pageof 153